InBioGen Co Ltd
KRX:101140
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (47.8), the stock would be worth ₩-1 673.24 (119% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -251.2 | ₩8 790 |
0%
|
| 3-Year Average | 47.8 | ₩-1 673.24 |
-119%
|
| 5-Year Average | 56.2 | ₩-1 966.43 |
-122%
|
| Industry Average | 2.5 | ₩-89.16 |
-101%
|
| Country Average | 5.4 | ₩-189.25 |
-102%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
|
InBioGen Co Ltd
KRX:101140
|
87.8B KRW | -251.2 | -61.9 | |
| US |
|
Nike Inc
NYSE:NKE
|
65.7B USD | 3.4 | 29.2 | |
| JP |
|
Asics Corp
TSE:7936
|
3.1T JPY | 6.6 | 31.2 | |
| US |
|
Deckers Outdoor Corp
NYSE:DECK
|
14.5B USD | 4 | 14 | |
| CH |
|
On Holding AG
NYSE:ONON
|
11.8B USD | 4.5 | 45.3 | |
| US |
|
Skechers USA Inc
NYSE:SKX
|
9.5B USD | 1.7 | 14.3 | |
| UK |
|
Birkenstock Holding PLC
NYSE:BIRK
|
7.1B USD | 5.8 | 16.3 | |
| CN |
|
Huali Industrial Group Co Ltd
SZSE:300979
|
44.5B CNY | 7.6 | 13.9 | |
| US |
|
Crocs Inc
NASDAQ:CROX
|
5.1B USD | 2.6 | -62.8 | |
| DE |
|
Puma SE
XETRA:PUM
|
3.8B EUR | 1.5 | -5.9 | |
| HK |
|
Yue Yuen Industrial (Holdings) Ltd
HKEX:551
|
23.3B HKD | 1.4 | 7.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 2.7 |
| Median | 5.4 |
| 70th Percentile | 10.1 |
| Max | 19 609.2 |
Other Multiples
InBioGen Co Ltd
Glance View
INBIOGEN CO., Ltd. engages in the manufacture and sale of footwear products. The company is headquartered in Seoul, Seoul and currently employs 56 full-time employees. The company went IPO on 2008-04-02. The firm operates its business through four segments. The Kiosk Business segment is engaged in the operation of unmanned payment machine business in restaurants, karaoke rooms, and personal computer (PC) rooms. The Footwear Business segment is mainly engaged in the sale of children's shoes and adult shoes. The Wood Pellet Business segment mainly sells wood pellets and sawdust. The Other Business segment engages in online and offline education business to foster human resources in the FinTech service, platform business, and block chain industry.
